US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY PROPEL OPPORTUNITIES ETF

17.06

-0.3172-1.83%

Post-market: 17.370.3172+1.86%19:30 EDT

Volume:271

Turnover:4.68K

Market Cap:73.85M

PE:- -

High:17.06

Open:17.15

Low:17.06

Close:17.37

52wk High:21.31

52wk Low:14.90

Shares:4.33M

Float Shares:4.33M

Volume Ratio:0.07

T/O Rate:0.01%

Dividend:2.72

Dividend Rate:15.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/SURI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SURI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","market":"US","secType":"STK","nameCN":"SIMPLIFY PROPEL OPPORTUNITIES ETF","latestPrice":17.0557,"timestamp":1790971200000,"preClose":17.3729,"halted":0,"volume":271,"hourTrading":{"tag":"盘后","latestPrice":17.3729,"preClose":17.0557,"latestTime":"19:30 EDT","volume":9,"amount":153.6342,"timestamp":1790983803507,"change":0.3172,"changeRate":0.018598,"amplitude":0},"delay":0,"changeRate":-0.018258321869117976,"floatShares":4330001,"shares":4330001,"eps":0,"marketStatus":"Market Closed","change":-0.3172,"latestTime":"10-02 16:00:00 EDT","open":17.15,"high":17.0557,"low":17.0557,"amount":4683.000053000001,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":17.3729,"sharesOutstanding":4520001,"nav":17.1382,"aum":74519842.9,"dividendRate":0.159507,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":17.37,"preClose":17.3729,"latestTime":"04:00 EDT","volume":1,"amount":17.37,"timestamp":1790928000454,"change":-0.0029,"changeRate":-0.000167,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.3729,"preClose":17.0557,"latestTime":"19:30 EDT","volume":9,"amount":153.6342,"timestamp":1790983803507,"change":0.3172,"changeRate":0.018598,"amplitude":0},"volumeRatio":0.06549373810261538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","floatShares":4330001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.06549373810261538,"shares":4330001,"dividePrice":2.7205,"high":17.0557,"amplitude":0,"preClose":17.3729,"low":17.0557,"week52Low":14.9001,"pbRate":"--","week52High":21.31,"institutionHeld":0,"latestPrice":17.0557,"eps":0,"divideRate":0.159507,"volume":271,"delay":0,"ttmEps":0,"open":17.15,"prevYearClose":16.675,"prevWeekClose":17.53,"prevMonthClose":17.5449,"prevQuarterClose":17.5449,"fiveDayClose":17.53,"twentyDayClose":20.3,"sixtyDayClose":18.2057},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SURI\",params:#limit:5,,,undefined,":[{"date":"2026-09-25","symbol":"SURI","amount":0.68,"announcedDate":"2026-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-25","defaultRemindTime":1790343000000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-25","currency":"USD","dateTimestamp":1790308800000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"SURI","amount":0.68,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"SURI","amount":0.68,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-09-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SURI\",market:\"US\",,,undefined,":[{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-03-31","value":1,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-07-03","value":0.68,"currency":"USD"},{"executeDate":"2023-09-27","recordDate":"2023-09-28","paymentDate":"2023-09-29","value":0.68,"currency":"USD"},{"executeDate":"2023-12-26","recordDate":"2023-12-27","paymentDate":"2023-12-29","value":0.68,"currency":"USD"},{"executeDate":"2024-03-25","recordDate":"2024-03-26","paymentDate":"2024-03-28","value":0.68,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SURI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SURI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","PBPH","CNCR","APXH","IBRN","LLYX","WDNA","GDOC","FHLC","MDTX","PSCH","SYNB","PSIL","XPH","HYLG","BBH","PBE","FBT","SBIO","PTH","HRTS","PINK","GNOM","BME","CANC","GPCR","MRNY","NVIB","BIB","CURE","LFSC","MEDX","JHMH","PJP","IEIH","SURI","IBB","TBXU","IBBQ","FXH","AZNH","MNTL","IDNA","RSPH","GNMX","IBBJ","MEDI","JDOC","FTXH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","GSKH","FHLC","IBBQ","APXH","PSCH","HYLG","SURI","PSIL","GPCR","FTXH","LENZ","BBP","CURE","RSPH","PBPH","TBXU","AZNH","BIB","MEDI","GDOC","MEDX","BBH","IBB","NVIB","JHMH","LLYX","IBBJ","FBT","GNOM","HRTS","SYNB","JDOC","XPH","PINK","MNTL","MDTX","FXH","SBIO","LFSC","BME","PTH","PJP","CANC","WDNA","IBRN","GNMX","PBE","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155684243","title":"BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1155684243","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155684243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:50","pubTimestamp":1786596641,"startTime":"0","endTime":"0","summary":"BofA Securities has released a report indicating that the Chinese CXO sector is poised to benefit from robust biotech venture capital funding. The bank notes that strong financing in the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","IE00BPRC5H50.USD","LU1979443071.USD","LU0348766576.USD","BMED","LU2242644610.SGD","603259","LU1997244956.HKD","BK1141","LU1719994722.HKD","LU1251922891.USD","MEDI","IBRN","LU2125910500.SGD","SMCO","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","BBC","APXH","IE00B5MMRT66.SGD","LFSC","02359","BK1576","FHLC","LU1808992512.USD","IE00B543WZ88.USD","LU0456842615.SGD","LU1934453819.USD","LU0708995583.HKD","XBIX","LU2488822045.USD","PSIL","LU0700851271.USD","IDNA","161027","CXO","LU1303224171.USD","LU0611395673.USD","LU2045819591.USD","PSCH","LU1997245094.SGD","LU0052750758.USD","BK1583","LU0320764599.SGD","BK0216","WX","LU1770034418.SGD","LU1046422090.SGD","LU0348767384.USD","SURI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111112440","title":"Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=1111112440","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111112440?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:35","pubTimestamp":1786588544,"startTime":"0","endTime":"0","summary":"A report from Bank of America Securities indicates that Chinese CRO/CDMO companies are poised to benefit from robust first-half funding in the global and Chinese biotech sectors, along with active...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU2242644610.SGD","603259","LU1997244956.HKD","LU1880383366.USD","LU1242518931.SGD","LU0128526141.USD","LU2328871848.SGD","IE00B5MMRT66.SGD","BK1576","LU0819121731.USD","IDNA","CXO","BK1521","LU0051755006.USD","WX","LU0516423174.USD","SG9999002562.SGD","LU0348767384.USD","LU0039217434.USD","IE00BPRC5H50.USD","LU1242518857.USD","BK1141","LU3063872942.SGD","LU0516423091.SGD","KURE","LU0307460666.USD","FHLC","LU0456846285.SGD","LU0348735423.USD","IE00B543WZ88.USD","LU1934453819.USD","LU0516422952.EUR","LU0708995583.HKD","XBIX","PSIL","LU0611395673.USD","LU2045819591.USD","03759","LU0417516902.SGD","LU0456827905.SGD","PSCH","LU1997245094.SGD","LU0052750758.USD","LU1770034418.SGD","LU0979878070.USD","LU0572944931.SGD","SURI","LU2495084118.USD","LU1979443071.USD","BMED","LU1719994722.HKD","MEDI","IBRN","LU2125910500.SGD","SMCO","LU1969619763.USD","LU1997245177.USD","LU0823426308.USD","BBC","LFSC","02359","BK1610","IE00B0JY6N72.USD","LU0359201612.USD","LU1808992512.USD","LU0140636845.USD","LU0326950275.SGD","SG9999002463.SGD","LU2488822045.USD","LU0181495838.USD","161027","LU1303224171.USD","LU0320764599.SGD","BK1583","BK0216","LU1046422090.SGD","LU0043850808.USD","LU1720050803.USD","LU1794554557.SGD","BK1589","LU0417516738.SGD","LU1251922891.USD","LU0348825331.USD","02269","LU0327786744.USD","APXH","LU0588546209.SGD","LU0456842615.SGD","LU0516422366.SGD","LU0856984785.SGD","LU0516422440.USD","LU2039709279.SGD","LU0700851271.USD","LU0823426480.USD","LU0359202008.SGD","LU0029874061.USD","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SURI\",params:#limit:6,delay:false,,,undefined,":[]}}